Home › Funds › Ikarian Capital, LLC › RCUS

Ikarian Capital, LLC position in RCUS

ARCUS BIOSCIENCES INC · Health Care

Ikarian Capital, LLC reported holding 504,559 shares of RCUS (ARCUS BIOSCIENCES INC) in its Q2 2026 13F filing — a position valued at US$15.6M, representing 2.50% of its reported portfolio and ranking #7 among its reported holdings. Ikarian Capital, LLC has disclosed RCUS holdings in 8 of the last 12 reported quarters, going back to Q3 2023.

Latest position (Q2 2026)504.56K sh
Reported value held$15.56M
Portfolio Weight2.50%
First reportedQ3 2023
Last changeNew
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How Ikarian Capital, LLC's RCUS position evolved

Ikarian Capital, LLC first disclosed a stake in RCUS in Q3 2023 at 254,876 shares (US$4.6M). The position peaked in Q2 2026 at 504,559 shares, worth US$15.6M. Across 8 filings, Ikarian Capital, LLC increased the stake 3 time(s), trimmed it 1 time(s) and left it unchanged 1 time(s). The most recent filing (Q2 2026) shows 504,559 shares valued at US$15.6M. Notable position changes include a 57% increase in Q4 2023 (shares fell 1% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 254.88K $4.58M New
Q4 2023 400.00K $7.64M Add
Q2 2024 145.00K $2.21M New
Q3 2024 113.70K $1.74M Reduce
Q4 2024 141.00K $2.10M Add
Q1 2025 163.36K $1.28M Add
Q2 2025 163.36K $1.33M Hold
Q2 2026 504.56K $15.56M New

Dots on the line are colored by change type; missing quarters mean no position was reported.

About RCUS and 13F data

RCUS (ARCUS BIOSCIENCES INC) is a Health Care company. 46 other funds we track also report a position in RCUS — the largest reported positions include GILEAD SCIENCES, INC. (US$968.8M), MONTANOVA CAPITAL, LLC (US$147.3M), Siren, L.L.C. (US$74.6M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding RCUS

All RCUS fund holders →

FAQ

How long has Ikarian Capital, LLC held RCUS?

Ikarian Capital, LLC has disclosed RCUS holdings in 8 of the last 12 reported quarters, going back to Q3 2023.

What is Ikarian Capital, LLC's current position in RCUS?

As of Q2 2026, Ikarian Capital, LLC holds 504.56K shares of RCUS (ARCUS BIOSCIENCES INC), valued at $15.56M, representing 2.50% of its reported portfolio and ranking #7.

Has Ikarian Capital, LLC been buying or selling RCUS?

In the latest 13F filing (Q2 2026), Ikarian Capital, LLC newly opened its position in RCUS. The position peaked in Q2 2026 at 504.56K shares.

Which other funds hold RCUS?

Other major institutional holders of RCUS include GILEAD SCIENCES, INC., MONTANOVA CAPITAL, LLC, Siren, L.L.C., among 46 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.